ServiceNow (NOW) 10-Q 23 Oct 24 2024 Q3 Quarterly report Financial data

Cover

Cover shares in Millions	9 Months Ended
	Sep. 30, 2024 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-35580
Entity Registrant Name	SERVICENOW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2056195
Entity Address, Address Line One	2225 Lawson Lane
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	501-8550
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	NOW
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares of common stock, outstanding (in shares)	206
Entity Central Index Key	0001373715
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,885	$ 1,897
Short-term investments	3,410	2,980
Accounts receivable, net	1,308	2,036
Current portion of deferred commissions	502	461
Prepaid expenses and other current assets	591	403
Total current assets	7,696	7,777
Deferred commissions, less current portion	946	919
Long-term investments	3,829	3,203
Property and equipment, net	1,718	1,358
Operating lease right-of-use assets	661	715
Intangible assets, net	214	224
Goodwill	1,291	1,231
Deferred tax assets	1,444	1,508
Other assets	635	452
Total assets	18,434	17,387
Current liabilities:
Accounts payable	165	126
Accrued expenses and other current liabilities	1,058	1,365
Current portion of deferred revenue	5,457	5,785
Current portion of operating lease liabilities	106	89
Total current liabilities	6,786	7,365
Deferred revenue, less current portion	77	81
Operating lease liabilities, less current portion	650	707
Long-term debt, net	1,489	1,488
Other long-term liabilities	142	118
Total liabilities	9,144	9,759
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value; shares authorized: 10,000; no shares issued or outstanding	0	0
Common stock, $0.001 par value; shares authorized: 600,000; shares issued: 207,693 and 205,619; shares outstanding: 206,317 and 204,724	0	0
Treasury stock, at cost (shares held: 1,376 and $895)	(926)	(535)
Additional paid-in capital	7,126	6,131
Accumulated other comprehensive loss	(20)	(37)
Retained earnings	3,110	2,069
Total stockholders’ equity	9,290	7,628
Total liabilities and stockholders’ equity	$ 18,434	$ 17,387
Shares of common stock, authorized (in shares)	600,000	600,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par or stated value per share (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par or stated value per share (in dollars per share)	$ 0.001	$ 0.001
Shares of common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, shares, issued (in shares)	207,693,000	205,619,000
Common stock, outstanding (in shares)	206,317,000	204,724,000
Treasury stock (in shares)	1,376,000	895,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Total revenues		$ 2,797	$ 2,288	$ 8,027	$ 6,534
Cost of revenues:
Total cost of revenues	[1]	584	496	1,656	1,405
Gross profit		2,213	1,792	6,371	5,129
Operating expenses:
Sales and marketing	[1]	944	799	2,827	2,454
Research and development	[1]	626	549	1,875	1,562
General and administrative	[1]	225	213	679	621
Total operating expenses	[1]	1,795	1,561	5,381	4,637
Income from operations		418	231	990	492
Interest income		108	82	313	216
Other expense, net		(10)	(14)	(28)	(47)
Income before income taxes		516	299	1,275	661
Provision for (benefit from) income taxes		84	57	234	(775)
Net income		$ 432	$ 242	$ 1,041	$ 1,436
Net income per share - basic (in USD per share)		$ 2.09	$ 1.18	$ 5.06	$ 7.04
Net income per share - diluted (in USD per share)		$ 2.07	$ 1.17	$ 5	$ 7
Weighted-average shares used to compute net income per share - basic (in shares)		206,158	204,464	205,639	203,961
Weighted-average shares used to compute net income per share - diluted (in shares)		208,552	206,277	208,004	205,194
Other comprehensive income (loss):
Foreign currency translation adjustments		$ 50	$ (64)	$ 3	$ (51)
Unrealized gain (loss) on investments, net of tax		60	(2)	44	(4)
Unrealized loss on derivative instruments, net of tax		(52)	0	(30)	0
Other comprehensive income (loss)		58	(66)	17	(55)
Comprehensive income		490	176	1,058	1,381
Subscription
Revenues:
Total revenues		2,715	2,216	7,780	6,315
Cost of revenues:
Total cost of revenues	[1]	496	420	1,406	1,163
Professional services and other
Revenues:
Total revenues		82	72	247	219
Cost of revenues:
Total cost of revenues	[1]	$ 88	$ 76	$ 250	$ 242
[1] Includes stock-based compensation as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cost of revenues: Subscription $ 64 $ 52 $ 184 $ 148 Professional services and other 11 11 35 40 Operating expenses: Sales and marketing 144 132 419 378 Research and development 150 150 479 430 General and administrative 57 68 175 195

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Stock-based compensation			$ 1,292	$ 1,191
Cost of revenues | Subscription
Stock-based compensation	$ 64	$ 52	184	148
Cost of revenues | Professional services and other
Stock-based compensation	11	11	35	40
Sales and marketing
Stock-based compensation	144	132	419	378
Research and development
Stock-based compensation	150	150	479	430
General and administrative
Stock-based compensation	$ 57	$ 68	$ 175	$ 195

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		202,882
Beginning balance at Dec. 31, 2022	$ 5,032	$ 0	$ 0	$ 4,796	$ 338	$ (102)
Beginning balance, treasury (in shares) at Dec. 31, 2022			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock and treasury stock issued under employee stock plans (in shares)	2,200	2,173	0
Common stock and Treasury stock issued under employee stock plans	$ 193		$ 0	193
Common stock repurchased	(282)		$ (282)
Common stock repurchased (in shares)			(500)
Taxes paid related to net share settlement of equity awards	(333)			(333)
Stock-based compensation	1,191			1,191
Other comprehensive income (loss), net of tax	(55)					(55)
Net income	1,436				1,436
Ending balance (in shares) at Sep. 30, 2023		205,055
Ending balance at Sep. 30, 2023	$ 7,182	$ 0	$ (282)	5,847	1,774	(157)
Ending balance, treasury (in shares) at Sep. 30, 2023			(500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(500)
Common stock repurchased	$ (282)
Beginning balance (in shares) at Jun. 30, 2023		204,267
Beginning balance at Jun. 30, 2023	6,926	$ 0	$ 0	5,485	1,532	(91)
Beginning balance, treasury (in shares) at Jun. 30, 2023			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock and treasury stock issued under employee stock plans (in shares)		788	0
Common stock and Treasury stock issued under employee stock plans	76		$ 0	76
Taxes paid related to net share settlement of equity awards	(127)			(127)
Stock-based compensation	413			413
Other comprehensive income (loss), net of tax	(66)					(66)
Net income	242				242
Ending balance (in shares) at Sep. 30, 2023		205,055
Ending balance at Sep. 30, 2023	$ 7,182	$ 0	$ (282)	5,847	1,774	(157)
Ending balance, treasury (in shares) at Sep. 30, 2023			(500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(500)		(500)
Common stock repurchased	$ (282)		$ (282)
Beginning balance (in shares) at Dec. 31, 2023		205,619
Beginning balance at Dec. 31, 2023	$ 7,628	$ 0	$ (535)	6,131	2,069	(37)
Beginning balance, treasury (in shares) at Dec. 31, 2023	(895)		(895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock and treasury stock issued under employee stock plans (in shares)	2,100	2,074	16
Common stock and Treasury stock issued under employee stock plans	$ 237		$ 9	228
Common stock repurchased	(400)		$ (400)
Common stock repurchased (in shares)			(497)
Taxes paid related to net share settlement of equity awards	(525)			(525)
Stock-based compensation	1,292			1,292
Other comprehensive income (loss), net of tax	17					17
Net income	1,041				1,041
Ending balance (in shares) at Sep. 30, 2024		207,693
Ending balance at Sep. 30, 2024	$ 9,290	$ 0	$ (926)	7,126	3,110	(20)
Ending balance, treasury (in shares) at Sep. 30, 2024	(1,376)		(1,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(500)
Common stock repurchased	$ (400)
Beginning balance (in shares) at Jun. 30, 2024		206,967
Beginning balance at Jun. 30, 2024	8,666	$ 0	$ (704)	6,770	2,678	(78)
Beginning balance, treasury (in shares) at Jun. 30, 2024			(1,110)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock and treasury stock issued under employee stock plans (in shares)		726	6
Common stock and Treasury stock issued under employee stock plans	106		$ 3	103
Taxes paid related to net share settlement of equity awards	(173)			(173)
Stock-based compensation	426			426
Other comprehensive income (loss), net of tax	58					58
Net income	432				432
Ending balance (in shares) at Sep. 30, 2024		207,693
Ending balance at Sep. 30, 2024	$ 9,290	$ 0	$ (926)	$ 7,126	$ 3,110	$ (20)
Ending balance, treasury (in shares) at Sep. 30, 2024	(1,376)		(1,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(300)		(272)
Common stock repurchased	$ (225)		$ (225)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 1,041	$ 1,436
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	410	408
Amortization of deferred commissions	403	333
Stock-based compensation	1,292	1,191
Deferred income taxes	47	(874)
Other	(31)	(13)
Changes in operating assets and liabilities, net of effect of business combinations:
Accounts receivable	727	552
Deferred commissions	(461)	(453)
Prepaid expenses and other assets	(267)	(183)
Accounts payable	42	(188)
Deferred revenue	(355)	(217)
Accrued expenses and other liabilities	(216)	(199)
Net cash provided by operating activities	2,632	1,793
Cash flows from investing activities:
Purchases of property and equipment	(599)	(433)
Business combinations, net of cash acquired	(82)	(279)
Purchases of other intangibles	(30)	(3)
Purchases of investments	(3,952)	(3,805)
Purchases of non-marketable investments	(149)	(56)
Sales and maturities of investments	3,024	2,868
Other	25	(15)
Net cash used in investing activities	(1,763)	(1,723)
Cash flows from financing activities:
Proceeds from employee stock plans	237	193
Repurchases of common stock	(400)	(282)
Taxes paid related to net share settlement of equity awards	(525)	(333)
Business combination	(184)	0
Net cash used in financing activities	(872)	(422)
Foreign currency effect on cash, cash equivalents and restricted cash	(8)	(4)
Net change in cash, cash equivalents and restricted cash	(11)	(356)
Cash, cash equivalents and restricted cash at beginning of period	1,904	1,475
Cash, cash equivalents and restricted cash at end of period	1,893	1,119
Cash, cash equivalents and restricted cash at end of period:
Cash and cash equivalents	1,885	1,112
Restricted cash included in prepaid expenses and other current assets	8	7
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	1,893	1,119
Supplemental disclosures of other cash flow information:
Interest paid	23	23
Income taxes paid, net of refunds	183	103
Non-cash investing and financing activities:
Property and equipment included in accounts payable, accrued expenses and other liabilities	$ 49	$ 63

Description of the Business

Description of the Business	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Business	Description of the Business ServiceNow was founded on a simple premise: to make work flow better. Our intelligent platform, the Now Platform, is a cloud-based solution with embedded artificial intelligence and machine learning capabilities that helps global enterprises across industries, universities and governments unify and digitize their workflows. Our workflow applications built on the Now Platform are organized along four primary areas: Technology, Customer and Industry, Employee and Creator. The products under each of our workflows help customers connect, automate and empower work across systems and silos to enable great outcomes for businesses and great experiences for people. The Now Platform orchestrates work across our customers’ cloud platforms and systems of choice, allowing our customers to get work done regardless of their current and future preferred systems of record and collaboration platforms.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by United States (“U.S.”) generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the condensed consolidated financial statements and footnote tables. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2023 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on January 25, 2024. Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates. In January 2024, we completed an assessment of the useful life of our data center equipment and determined we should increase the estimated useful life of data center equipment from four years to five years. This change in accounting estimate was effective beginning fiscal year 2024. Based on the carrying amount of data center equipment included in property and equipment, net as of December 31, 2023, the effect of this change in estimate for the three and nine months ended September 30, 2024, was a reduction in depreciation expense of $24 million and $81 million, respectively, and an increase in net income of $21 million and $65 million, or $0.10 and $0.31 per share basic and $0.10 and $0.31 per share diluted, respectively. Significant Accounting Policies We have incorporated two updates to our significant accounting policies during the nine months ended September 30, 2024. The first is the change in useful life of our data center equipment discussed above and the second is related to our cash flow hedging program initiated during the quarter ended March 31, 2024 to hedge a portion of our forecasted foreign currency denominated revenues as discussed below. There were no other updates to our significant accounting policies disclosed in “Note 2 – Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2023. Derivative Financial Instruments Cash flow hedging We record derivatives at fair value as either assets or liabilities on our condensed consolidated balance sheets. For derivative contracts entered into to hedge a portion of our forecasted foreign currency denominated revenues that are designated and qualify as cash flow hedges, the unrealized gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings as subscription revenues when the hedged transaction affects earnings. Derivatives not designated as hedging instruments are adjusted to fair value through earnings as other expense, net in the period during which changes in fair value occur. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. We also formally assess, both at the inception of the hedge, and on an ongoing basis, whether each derivative is highly effective in offsetting changes in cash flows of the hedged item. Fluctuations in the value of the derivative instruments are generally offset by changes in the hedged item; however, if it is determined that a derivative is not highly effective as a hedge or if a derivative ceases to be a highly effective hedge, the Company will discontinue hedge accounting prospectively for the affected derivative. Concentration of Credit Risk and Significant Customers Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. We had one customer, a U.S. federal channel partner and systems integrator, that represented 27% of our accounts receivable balance as of September 30, 2024 and 11% of our total revenues for each of the three and nine months ended September 30, 2024. Based on our periodic credit evaluations, there have been no historical collection concerns with this customer. There were no customers that individually exceeded 10% of our accounts receivable balance as of December 31, 2023 or our total revenues for each of the three and nine months ended September 30, 2023. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer. Revision of Prior Period Financial Statement s During the quarter ended June 30, 2024, the Company identified an immaterial error in the condensed consolidated statements of cash flows for the period ended March 31, 2024 relating to a misclassification between investing cash outflows and financing cash outflows. The second installment payment for a business combination completed during the quarter ended September 30, 2023, totaling $184 million, was incorrectly classified as an investing cash outflow instead of a financing cash outflow. The Company determined that the error was not material to any previously issued financial statements and will revise such error in its Quarterly Report on Form 10-Q for the three months ending March 31, 2025.

Investments

Investments	9 Months Ended
	Sep. 30, 2024
Debt Securities, Available-for-Sale [Abstract]
Investments	Investments Marketable Debt Securities The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): September 30, 2024 Amortized Gross Gross Estimated Available-for-sale debt securities: Commercial paper $ 297 $ 1 $ — $ 298 Corporate notes and bonds 4,566 41 (1) 4,606 Certificates of deposit 42 — — 42 U.S. government and agency securities 2,196 9 (1) 2,204 Mortgage-backed and asset-backed securities 103 — (14) 89 Total available-for-sale debt securities $ 7,204 $ 51 $ (16) $ 7,239 December 31, 2023 Amortized Gross Gross Estimated Available-for-sale debt securities: Commercial paper $ 349 $ — $ — $ 349 Corporate notes and bonds 3,579 10 (13) 3,576 Certificates of deposit 94 — — 94 U.S. government and agency securities 2,081 3 (6) 2,078 Mortgage-backed and asset-backed securities 102 — (16) 86 Total available-for-sale debt securities $ 6,205 $ 13 $ (35) $ 6,183 As of September 30, 2024, the contractual maturities of our available-for-sale debt securities, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheet and mortgage-backed and asset-backed securities that do not have a single maturity, did not exceed 37 months. The fair values of available-for-sale debt securities, by remaining contractual maturity, are as follows (in millions): September 30, 2024 Due within 1 year $ 3,410 Due in 1 year through 5 years 3,740 Instruments not due in single maturity 89 Total $ 7,239 As of September 30, 2024, unrealized losses of $16 million from available-for-sale debt securities are from securities in a continuous unrealized loss position greater than 12 months. As of September 30, 2024, the fair value of available-for-sale debt securities in a continuous unrealized loss position totaled $1,419 million, the majority of which has been in a continuous unrealized loss position for greater than 12 months. As of December 31, 2023, the fair value of available-for-sale debt securities in a continuous unrealized loss position totaled $3,731 million. For all available-for-sale debt securities that were in unrealized loss positions, we have determined that it is more likely than not we will hold the securities until maturity or a recovery of the cost basis. Unrealized losses on available-for-sale debt securities were due primarily to changes in market interest rates, and credit-related impairment losses were immaterial as of September 30, 2024. Non-Marketable Equity Investments As of September 30, 2024 and December 31, 2023, the total amount of non-marketable equity investments in privately held companies included in other assets on our condensed consolidated balance sheets was $396 million and $268 million, respectively. Our non-marketable equity investments are primarily accounted for using the measurement alternative, which measures the investments at cost, minus impairment, if any, plus or minus changes resulting from qualifying observable price changes resulting from the issuance of similar or identical securities in an orderly transaction by the same issuer. Determining whether an observed transaction is similar to a security within our portfolio requires judgment based on the rights and preferences of the securities. Recording upward and downward adjustments to the carrying value of our non-marketable equity investments as a result of observable price changes requires quantitative assessments of the fair value of our non-marketable equity investments using various valuation methodologies and involves the use of estimates. The adjustments made during the three and nine months ended September 30, 2024 and 2023 were immaterial. We classify these fair value measurements as Level 3 within the fair value hierarchy.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of September 30, 2024 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,162 $ — $ 1,162 Commercial paper — 44 44 Deposits 238 — 238 U.S. government and agency securities — 4 4 Marketable securities: Commercial paper — 298 298 Corporate notes and bonds — 4,606 4,606 Certificates of deposit — 42 42 U.S. government and agency securities — 2,204 2,204 Mortgage-backed and asset-backed securities — 89 89 Total $ 1,400 $ 7,287 $ 8,687 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2023 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,215 $ — $ 1,215 Commercial paper — 79 79 Corporate notes and bonds — 2 2 Deposits 295 — 295 U.S. government and agency securities — 4 4 Marketable securities: Commercial paper — 349 349 Corporate notes and bonds — 3,576 3,576 Certificates of deposit — 94 94 U.S. government and agency securities — 2,078 2,078 Mortgage-backed and asset-backed securities — 86 86 Total $ 1,510 $ 6,268 $ 7,778 We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs), pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs that are supported by little or no market activity (Level 3 inputs). Our non-marketable equity investments are not included in the table above and are discussed in Note 3. See Note 8 for the fair value measurement of our derivative contracts and Note 10 for the fair value measurement of our long-term debt, which are also not included in the table above. Our marketable equity investments are classified within Level 1 and were immaterial as of September 30, 2024 and December 31, 2023.

Business Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combinations	Business Combinations During the nine months ended September 30, 2024, we completed certain acquisitions for total purchase consideration of $81 million primarily to enhance our products with the acquired technology and engineering workforce. The acquisitions were not material to our condensed consolidated financial statements, either individually or in the aggregate. On July 17, 2023, we acquired all outstanding shares of G2K Group GmbH, an artificial intelligence powered platform, for $465 million in a cash transaction. The consideration was paid in two installments, with the first payment made in July 2023 and the second payment made in February 2024. The acquisition is intended to enhance our Now Platform with the acquired smart Internet of Things technology, enabling businesses to intelligently action digital and in-store data with enterprise-grade workflows. The purchase price was allocated based on the estimated fair value of the developed technology intangible asset of $75 million (six-year estimated useful life), net tangible liabilities of $1 million, deferred tax liabilities of $23 million and goodwill of $414 million, which is not deductible for income tax purposes. Goodwill is primarily attributed to the value expected from synergies resulting from the business combination. The fair values assigned to tangible and intangible assets acquired, liabilities assumed and income taxes payable and deferred taxes are based on management’s estimates and assumptions.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The changes in the carrying amounts of goodwill were as follows (in millions): Carrying Amount Balance as of December 31, 2023 $ 1,231 Goodwill acquired 58 Foreign currency translation adjustments 2 Balance as of September 30, 2024 $ 1,291 Intangible assets, net consists of the following (in millions): September 30, 2024 December 31, 2023 Developed technology $ 575 $ 516 Patents 73 72 Other 11 11 Intangible assets, gross 659 599 Less: accumulated amortization (445) (375) Intangible assets, net $ 214 $ 224 The weighted-average useful life of the acquired developed technology for the nine months ended September 30, 2024 and 2023 was approximately five years. Amortization expense for intangible assets for the three months ended September 30, 2024 and 2023 was $23 million and $21 million, respectively, and for the nine months ended September 30, 2024 and 2023 was $71 million and $63 million, respectively. The following table presents the estimated future amortization expense related to intangible assets held at September 30, 2024 (in millions): Years Ending December 31, Remainder of 2024 $ 22 2025 76 2026 45 2027 31 2028 26 Thereafter 14 Total future amortization expense $ 214

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consists of the following (in millions): September 30, 2024 December 31, 2023 Computer equipment $ 2,642 $ 2,136 Computer software 107 96 Leasehold and other improvements 316 292 Furniture and fixtures 88 86 Construction in progress 43 33 Property and equipment, gross 3,196 2,643 Less: Accumulated depreciation (1,478) (1,285) Property and equipment, net $ 1,718 $ 1,358 Construction in progress consists of costs primarily related to leasehold and other improvements. Depreciation expense for the three months ended September 30, 2024 and 2023 was $96 million and $98 million, respectively, and for the nine months ended September 30, 2024 and 2023 was $264 million and $267 million, respectively.

Derivative Contracts

Derivative Contracts	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Contracts	Derivative Contracts Derivatives Designated as Hedging Instruments We entered into forward contracts to hedge a portion of our forecasted foreign currency denominated revenues during the three and nine months ended September 30, 2024. These forward contracts are recorded at fair value and have maturities of up to 34 months. As of September 30, 2024, we had outstanding cash flow hedges with total notional values of $1.6 billion. We classify cash flows related to our cash flow hedges as operating activities in our condensed consolidated statements of cash flows. The total gross fair values of derivatives designated as hedging instruments recorded within the condensed consolidated balance sheets were as follows (in millions): Condensed Consolidated Balance Sheets Location September 30, 2024 Accrued expenses and other current liabilities $ 25 Other long-term liabilities $ 10 As of September 30, 2024, approximately $25 million of the pre-tax derivative loss from accumulated other comprehensive income (loss) is expected to be recognized in subscription revenues To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. We evaluate hedge effectiveness at the inception of the hedge prospectively, and on an ongoing basis both retrospectively and prospectively. We report changes in fair value of these cash flow hedges as a component of accumulated other comprehensive income (loss) and subsequently reclassify into earnings in the same period the forecasted transaction affects earnings. Amounts reclassified to subscription revenues were a loss of $2 million for the three months ended September 30, 2024 and a gain of $3 million for the nine months ended September 30, 2024. There was no ineffectiveness in the Company’s cash flow hedging program for each of the three and nine months ended September 30, 2024. Derivatives not Designated as Hedging Instruments Our derivatives not designated as hedging instruments consist of foreign currency forward contracts that we primarily use to hedge monetary assets and liabilities denominated in non-functional currencies. These foreign currency forward contracts are recorded at fair value and have maturities of 12 months or less. The changes in the fair value of these contracts are recorded in other expense, net on the condensed consolidated statements of comprehensive income. As of September 30, 2024 and December 31, 2023, we had foreign currency forward contracts with total notional values of $2.3 billion and $1.7 billion, respectively, which were not designated as hedging instruments. The gross fair value of these foreign currency forward contracts was immaterial as of September 30, 2024 and December 31, 2023. The gains (losses) recognized for these foreign currency forward contracts from derivatives not designated as hedging instruments were immaterial for each of the three and nine months ended September 30, 2024 and 2023. All foreign currency forward contracts, both designated and not designated as hedging instruments, are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Revenues recognized from beginning period deferred revenue during the three months ended September 30, 2024 and 2023 were $2.5 billion and $2.0 billion, respectively, and $5.1 billion and $4.1 billion for the nine months ended September 30, 2024 and 2023, respectively. Remaining Performance Obligations Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancellable amounts that will be invoiced and recognized as revenues in future periods. RPO excludes contracts that are billed in arrears, such as certain time and materials contracts, as we apply the “right to invoice” practical expedient under relevant accounting guidance. As of September 30, 2024, the total non-cancellable RPO under our contracts with customers was $19.5 billion and we expect to recognize revenues on approximately 48% of these RPO over the following 12 months. The majority of the non-current RPO will be recognized over the next 13 to 36 months.

Debt

Debt	9 Months Ended
	Sep. 30, 2024
Convertible Notes Payable [Abstract]
Debt	Debt For the periods ended September 30, 2024 and December 31, 2023, the carrying value of our outstanding debt was $1,489 and $1,488 million, respectively, net of unamortized debt discount and issuance costs of $11 million and $12 million, respectively. We consider the fair value of the 2030 Notes at September 30, 2024 and December 31, 2023 to be a Level 2 measurement. The estimated fair value of the 2030 Notes based on the closing trading price per $100, was $1,290 million and $1,236 million at September 30, 2024 and December 31, 2023, respectively. 2030 Notes In August 2020, we issued 1.40% fixed rate ten-year notes with an aggregate principal amount of $1.5 billion due on September 1, 2030 (the “2030 Notes”). The 2030 Notes were issued at 99.63% of principal and we incurred $13 million for debt issuance costs. The effective interest rate for the 2030 Notes was 1.53% and included interest payable, amortization of debt issuance cost and amortization of debt discount. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2021, and the entire outstanding principal amount is due at maturity on September 1, 2030. The 2030 Notes are unsecured obligations and the indentures governing the 2030 Notes contain customary events of default and covenants that, among others and subject to exceptions, restrict our ability to incur or guarantee debt secured by liens on specified assets or enter into sale and lease-back transactions with respect to specified properties.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Income (Loss) The following tables show the components of accumulated other comprehensive income (loss), net of tax, in the stockholders’ equity section of our condensed consolidated balance sheets (in millions): Unrealized Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Foreign Currency Translation Adjustment Total Balance as of December 31, 2023 $ — $ (39) $ 2 $ (37) Other comprehensive (loss) income before reclassifications (27) 44 3 20 Amounts reclassified from accumulated other comprehensive loss (3) — — (3) Net current period other comprehensive (loss) income (30) 44 3 17 Balance as of September 30, 2024 $ (30) $ 5 $ 5 $ (20) Unrealized Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Foreign Currency Translation Adjustment Total Balance as of December 31, 2022 $ — $ (77) $ (25) $ (102) Other comprehensive loss before reclassifications — (4) (51) (55) Amounts reclassified from accumulated other comprehensive loss — — — — Net current period other comprehensive loss — (4) (51) (55) Balance as of September 30, 2023 $ — $ (81) $ (76) $ (157)

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock We are authorized to issue a total of 600 million shares of common stock as of September 30, 2024. Holders of our common stock are not entitled to receive dividends unless declared by our board of directors. As of September 30, 2024, we had 206.3 million shares of common stock, net of treasury stock, outstanding and had reserved shares of common stock for future issuance as follows (in thousands): September 30, 2024 Stock plans: Options outstanding 948 RSUs (1) 6,354 Shares of common stock available for future grants: Amended and Restated 2021 Equity Incentive Plan (2) 9,579 Amended and Restated 2012 Employee Stock Purchase Plan (2) 8,119 Total shares of common stock reserved for future issuance 25,000 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed in Note 13. (2) Refer to Note 13 for a description of these plans. We issued a total of 2.1 million and 2.2 million shares for the nine months ended September 30, 2024 and 2023, respectively, from stock option exercises, vesting of RSUs, net of employee payroll taxes, and purchases from the employee stock purchase plan (“ESPP”). Treasury Stock In May 2023, our board of directors authorized a program to repurchase up to $1.5 billion of our common stock (the “Share Repurchase Program”). Under this new program, we may repurchase our common stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions. The Share Repurchase Program does not have a fixed expiration date, may be suspended or discontinued at any time, and does not obligate us to acquire any amount of common stock. The timing, manner, price, and amount of any repurchases will be determined by us at our discretion and will depend on a variety of factors, including business, economic and market conditions, prevailing stock prices, corporate and regulatory requirements, and other considerations. During the three and nine months ended September 30, 2024, the Company repurchased 0.3 million and 0.5 million shares of its common stock for $225 million and $400 million, respectively. During the three and nine months ended September 30, 2023, the Company repurchased 0.5 million shares of its common stock for $282 million. All repurchases were made in open market transactions. Repurchases of common stock are recognized as treasury stock and held for future issuance. As of September 30, 2024, approximately $562 million of the originally authorized amount under the Share Repurchase Program remained available for future repurchases.

Equity Awards

Equity Awards	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity Awards	Equity Awards We currently have three equity incentive plans: 2012 Equity Incentive Plan (the “2012 Plan”), amended and restated 2021 Equity Incentive Plan (the “2021 Plan”) and 2022 New-Hire Equity Incentive Plan (the “2022 Plan”). The 2012 Plan was terminated in connection with the initial approval of the 2021 Plan on June 7, 2021 but continues to govern the terms of outstanding equity awards that were granted prior to the termination of the 2012 Plan. As of June 7, 2021, we no longer grant equity awards pursuant to the 2012 Plan. The 2021 Plan, as amended and restated, was approved by the shareholders on June 1, 2023 to increase shares available for future grants by approximately 10 million shares. Upon effectiveness of the 2021 Plan, as amended and restated, the 2022 Plan was terminated, and no additional awards under the 2022 Plan have been made since the amendment and restatement of the 2021 Plan. Outstanding equity awards under the 2022 Plan continue to be subject to the terms and conditions of the 2022 Plan. The 2021 Plan and the 2012 Plan provide for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, RSUs, performance-based stock awards and other forms of equity compensation (collectively, “equity awards”). The 2022 Plan permits the grant of any of the foregoing awards with the exception of incentive stock options. In addition, the 2022 Plan, the 2021 Plan and the 2012 Plan provide for the grant of performance cash awards. Incentive stock options may be granted only to employees. All other equity awards may be granted to employees, including officers, as well as directors and consultants. Our Amended and Restated 2012 Employee Stock Purchase Plan (the “2012 ESPP”) authorizes the issuance of shares of common stock pursuant to purchase rights granted to our employees. The price at which common stock is purchased under the 2012 ESPP is equal to 85% of the fair market value of our common stock on the first or last day of the offering period, whichever is lower. Offering periods are six months long and begin on February 1 and August 1 of each year. The number of shares of common stock reserved for issuance will not be increased without shareholder approval. Stock Options A summary of stock option activity for the nine months ended September 30, 2024 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2023 1,150 $ 603.30 Exercised (74) $ 327.00 $ 34 Forfeited (128) $ 645.02 Outstanding at September 30, 2024 948 $ 619.04 6.8 $ 261 Vested and expected to vest as of September 30, 2024 837 $ 610.33 6.8 $ 238 Vested and exercisable as of September 30, 2024 238 $ 433.25 5.9 $ 110 Aggregate intrinsic value represents the difference between the estimated fair value of our common stock and the exercise price of outstanding, in-the-money options. The total fair value of stock options vested during the nine months ended September 30, 2024 was $41 million. No stock options were granted during the nine months ended September 30, 2024. During the year ended December 31, 2021, a one-time long-term performance-based option award was granted to the Chief Executive Officer (“2021 CEO Performance Award”) and to certain executives (collectively “2021 Performance Awards”) under the 2021 Plan at a total grant date fair value of $232 million. The 2021 Performance Awards will vest in eight equal tranches based on service and achievement of both performance and market conditions, subject to continued employment and specifically for the 2021 CEO Performance Award, as CEO or Executive Chairman of the Company, through each vesting date. The performance and market conditions for a particular tranche may be achieved at different points in time and in any order but will become eligible to vest only when all service, performance and market conditions for the respective tranche are met but no earlier than two years from date of grant. The performance and market conditions must be achieved by September 30, 2026 (the “Performance Period”). The stock price metric will be achieved when both the 180-day volume weighted-average price (“VWAP”) and the 30-day VWAP equal or exceed the respective tranche stock price metric on any day during the Performance Period. The performance metric is achieved when the trailing four-quarter cumulative GAAP subscription revenues equal or exceed the respective tranche performance target. Shares acquired upon exercise of the options cannot be sold, transferred or disposed until after the end of the Performance Period and the 2021 Performance Awards will expire ten years from the respective date of grant. During the nine months ended September 30, 2024, the first tranche was vested based on the achievement of both the performance and market conditions. The fair value of the 2021 Performance Awards and the corresponding derived service periods were estimated using the Monte Carlo simulation. Stock-based compensation expense is recognized on a graded vesting basis over the requisite service period for each respective tranche, but not shorter than the two-year minimum service period, and includes an assessment of when it is probable the performance condition will be achieved, which involves a subjective assessment of our future financial projections. As of September 30, 2024, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options was $10 million. The weighted-average remaining vesting period of unvested stock options at September 30, 2024 was approximately one year. RSUs A summary of RSU activity for the nine months ended September 30, 2024 was as follows: Number of Weighted-Average Grant-Date Fair Value (in thousands) Outstanding at December 31, 2023 6,262 $ 506.77 Granted 2,866 $ 778.65 Vested (2,309) $ 537.32 Forfeited (465) $ 562.17 Outstanding at September 30, 2024 6,354 $ 614.27 Expected to vest as of September 30, 2024 5,698 RSUs outstanding as of September 30, 2024 were comprised of 5.9 million RSUs with only service conditions and 0.5 million RSUs with both service and performance conditions, including certain RSUs with additional market conditions. The total intrinsic value of the RSUs vested was $1.8 billion for the nine months ended September 30, 2024. As of September 30, 2024, the aggregate intrinsic value of RSUs outstanding was $5.7 billion and RSUs expected to vest was $5.1 billion. PRSUs have service, performance and market vesting criteria. The ultimate number of shares eligible to vest range from 0% to 200%, subject to our board of directors compensation committee’s approval of performance metrics achievement and, for certain PRSUs, total shareholder return relative to that of the S&P 500 index. The eligible shares subject to PRSUs granted during the nine months ended September 30, 2024 will vest in one As of September 30, 2024, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested RSUs was $3.1 billion, and the weighted-average remaining vesting period was approximately three years.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share Basic net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted for the effects of dilutive shares of common stock, which are comprised of outstanding stock options, RSUs and ESPP obligations. Stock awards with performance or market conditions are included in dilutive shares to the extent all conditions are met. The potentially dilutive shares of common stock are computed using the treasury stock method or the as-if converted method, as applicable. The effects of outstanding stock options, RSUs and ESPP obligations are excluded from the computation of diluted net income per share in periods in which the effect would be antidilutive. The following table presents the calculation of basic and diluted net income per share attributable to common stockholders (in millions, except for number of shares reflected in thousands and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net income $ 432 $ 242 $ 1,041 $ 1,436 Denominator: Weighted-average shares outstanding - basic 206,158 204,464 205,639 203,961 Weighted-average effect of potentially dilutive securities: Common stock options 131 122 138 118 RSUs 2,258 1,674 2,218 1,113 ESPP obligations 5 17 9 2 Weighted-average shares outstanding - diluted 208,552 206,277 208,004 205,194 Net income per share - basic $ 2.09 $ 1.18 $ 5.06 $ 7.04 Net income per share - diluted $ 2.07 $ 1.17 $ 5.00 $ 7.00 Common stock options, RSUs and ESPP obligations excluded from diluted net income per share because their effect would have been anti-dilutive 1,082 3,068 2,715 3,647

Provision for (Benefit from) In

Provision for (Benefit from) Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Provision for (Benefit from) Income Taxes	Provision for (Benefit from) Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period. Our income tax provision was $84 million and $234 million for the three and nine months ended September 30, 2024, respectively. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates, offset by excess tax benefits of stock-based compensation. The income tax provision was $57 million for the three months ended September 30, 2023, and our income tax benefit was $775 million for the nine months ended September 30, 2023. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates, tax deductible research and development costs and the valuation allowance release through the effective tax rate. The income tax benefit was primarily attributable to the release of the valuation allowance of certain U.S. federal and state deferred tax assets. We regularly assess the need for a valuation allowance against our deferred tax assets. In making that assessment, we consider both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. As of June 30, 2023, we achieved cumulative U.S. income during the prior twelve quarters when considering pre-tax income adjusted for permanent differences and other comprehensive losses. Based on all available positive and negative evidence, having demonstrated sustained profitability which is objective and verifiable, and taking into account anticipated future earnings, we concluded it is more likely than not that our U.S. federal and state deferred tax assets will be realizable, with the exception of California. We released $985 million of our valuation allowance during the nine months ended September 30, 2023. As of September 30, 2024, we continue to maintain a valuation allowance against our California deferred tax assets due to the uncertainty regarding realizability of these deferred tax assets as they have not met the “more likely than not” realization criteria, particularly as we expect research and development tax credit generation to exceed our ability to use the credits in future years. We will continue to monitor the need for a valuation allowance against our deferred tax assets on a quarterly basis. We are subject to taxation in the United States and foreign jurisdictions. As of September 30, 2024, our tax years 2004 to 2023 remain subject to examination in most jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases For some of our offices and data centers, we have entered into non-cancellable operating lease agreements with various expiration dates through 2035. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into our determination of lease payments. Total operating lease costs were $33 million and $98 million for the three and nine months ended September 30, 2024, respectively, and $33 million and $96 million for the three and nine months ended September 30, 2023, respectively. For each of the nine months ended September 30, 2024 and 2023, total cash paid for amounts included in the measurement of operating lease liabilities was $61 million. Operating lease liabilities arising from obtaining operating right-of-use assets totaled $21 million and $93 million for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, the weighted-average remaining lease term is approximately eight years, and the weighted-average discount rate is 4%. Maturities of operating lease liabilities as of September 30, 2024 are presented in the table below (in millions): Remainder of 2024 $ 31 2025 135 2026 112 2027 97 2028 91 Thereafter 428 Total operating lease payments 894 Less: imputed interest (138) Present value of operating lease liabilities $ 756 In addition to the amounts above, as of September 30, 2024, we have one operating lease for office space that has not yet commenced with undiscounted cash flows of $50 million. This operating lease is expected to commence during 2025 with a lease term of ten years. Other Commitments Other contractual commitments primarily consist of data center and IT operations and sales and marketing activities related to our daily business operations. There were no material contractual obligations that were entered into during the nine months ended September 30, 2024 that were outside the ordinary course of business. We have entered into various non-cancellable agreements with cloud service providers, under which we have committed to spend an aggregate of $805 million through 2029 on cloud services. In addition to the amounts above, the repayment of our 2030 Notes with an aggregate principal amount of $1.5 billion is due on September 1, 2030. Refer to Note 10 for further information regarding our 2030 Notes. Further, $60 million of unrecognized tax benefits have been recorded as liabilities as of September 30, 2024. Legal Proceedings We are party to certain litigation and other legal proceedings. While legal proceedings are inherently unpredictable and subject to uncertainties, we do not believe the ultimate resolution of any such proceedings is likely to result in a material loss. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. On July 5, 2022, InQuisient Inc. (“Plaintiff”) filed a complaint against ServiceNow, Inc. in the U.S. District Court for the District of Delaware, alleging the Now Platform’s use of relational databases infringes three of Plaintiff’s patents. Plaintiff is seeking injunctive relief and unspecified damages. The Company filed an answer denying Plaintiff’s allegations and asserts Plaintiff’s patents are, among other things, invalid, not infringed and otherwise unenforceable. A trial date has been set for January 27, 2025. While the Company continues to vigorously defend this matter, we cannot predict the outcome with any degree of certainty. We are unable to reasonably estimate the possible loss or range of loss, if any. Any adverse determination related to intellectual property claims or other litigation could prevent us from offering our services and adversely affect our financial condition and results of operations. For additional information regarding intellectual property litigation, see “Risk Factors—Lawsuits by third parties that allege we infringe their intellectual property rights could harm our business and operating results” and “Risk Factors—Our intellectual property protections may not provide us with a competitive advantage, and defending our intellectual property may result in substantial expenses that harm our operating results” included in our Annual Report on Form 10-K for the year ended December 31, 2023. Other As previously disclosed, through its internal processes, the Company received a complaint that raised potential compliance issues related to one of its government contracts. The Company initiated an internal investigation, with the assistance of outside legal counsel, into the validity of these claims that concern the hiring of the Chief Information Officer of the U.S. Army as the Company’s Head of Global Public Sector in March 2023. As a result of the investigation, the Company’s Board of Directors determined that the Company’s President and Chief Operating Officer and the hired individual violated Company policy regarding a possible conflict relating to such individual’s hiring. On July 24, 2024, the Company and its President and Chief Operating Officer came to a mutual agreement that he would resign from all positions with the Company, effective immediately. The other individual also has departed the Company. The Company has informed the Department of Justice, the Department of Defense Office of Inspector General and the Army Suspension and Debarment Office of the investigation and is continuing to cooperate with the Department of Justice, which has commenced its own investigation into these matters. The Company cannot predict the timing, outcome or possible impact of the investigation. Indemnification Provisions Our agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, we have entered into indemnification agreements with our directors, executive officers and certain other officers that will require us, among other things, to indemnify them against certain liabilities that may arise as a result of their affiliation with us. We have not incurred any costs as a result of such indemnification obligations and have not recorded any liabilities related to such obligations in the condensed consolidated financial statements.

Information about Geographic Ar

Information about Geographic Areas and Products	9 Months Ended
	Sep. 30, 2024
Segments, Geographical Areas [Abstract]
Information about Geographic Areas and Products	Information about Geographic Areas and Products Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 North America (1) $ 1,778 $ 1,452 $ 5,080 $ 4,165 EMEA (2) 700 585 2,037 1,664 Asia Pacific and other 319 251 910 705 Total revenues $ 2,797 $ 2,288 $ 8,027 $ 6,534 Property and equipment, net by geographic area were as follows (in millions): September 30, 2024 December 31, 2023 North America (3) $ 1,080 $ 871 EMEA (2) 426 312 Asia Pacific and other 212 175 Total property and equipment, net $ 1,718 $ 1,358 (1) Revenues attributed to the United States were 94% of North America revenues for each of the three and nine months ended September 30, 2024 and 2023. (2) Europe, the Middle East and Africa (“EMEA”). (3) Property and equipment, net attributed to the United States were 78% and 79% of property and equipment, net attributable to North America as of September 30, 2024 and December 31, 2023, respectively. Subscription revenues consist of the following (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Digital workflow products $ 2,398 $ 1,961 $ 6,877 $ 5,587 ITOM products 317 255 903 728 Total subscription revenues $ 2,715 $ 2,216 $ 7,780 $ 6,315

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income	$ 432	$ 242	$ 1,041	$ 1,436

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024 shares	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Russell Elmer [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Russell Elmer, our General Counsel, adopted a trading plan on August 13, 2024. The plan, which expires May 20, 2025, provides for the sale of 2,511 shares of our common stock during the plan period. The plan also provides for the sale of up to 100% of the net vested shares resulting from the vesting of 9,149 restricted stock units and performance stock units during the plan period and subject to certain vesting conditions. Net vested shares are net of tax withholding.
Name	Russell Elmer
Title	General Counsel
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 13, 2024
Expiration Date	May 20, 2025
Arrangement Duration	280 days
Paul Smith [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Paul Smith, our Chief Commercial Officer, adopted a trading plan on August 13, 2024. The plan, which expires May 20, 2025, provides for the sale of 1,153 shares of our common stock during the plan period. The plan also provides for the sale of (i) up to 50% of the net vested shares resulting from the vesting of 10,757 restricted stock units and performance stock units, (ii) up to 15% of the gross vested shares resulting from the vesting of 1,019 restricted stock units and (iii) up to 100% of the net vested shares resulting from the vesting of 7,902 restricted stock units and performance stock units, in each case, during the plan period and subject to certain vesting conditions. Net vested shares are net of tax withholding.
Name	Paul Smith
Title	Chief Commercial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 13, 2024
Expiration Date	May 20, 2025
Arrangement Duration	280 days
William R. McDermott [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		William R. McDermott, our Chief Executive Officer, adopted a trading plan on August 19, 2024. The plan, which expires August 7, 2025, provides for the sale of up to 21,972 shares of our common stock during the plan period. The plan also provides for the sale of up to 100% of the net vested shares resulting from the vesting of 15,892 restricted stock units and performance stock units during the plan period and subject to certain vesting conditions. Net vested shares are net of tax withholding.
Name	William R. McDermott
Title	Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 19, 2024
Expiration Date	August 7, 2025
Arrangement Duration	353 days
Anita Sands [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Anita Sands, a member of our board of directors, adopted a trading plan on August 26, 2024. The plan, which expires May 30, 2025, provides for the sale of (i) 2,229 shares of our common stock, (ii) up to 50% of the net vested shares from the vesting of 428 restricted stock units and (iii) up to 100% of the net vested shares resulting from the vesting of 214 restricted stock units, in each case, during the plan period and subject to certain vesting conditions.
Name	Anita Sands
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 26, 2024
Expiration Date	May 30, 2025
Arrangement Duration	277 days
Paul Chamberlain [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Paul Chamberlain, a member of our board of directors, adopted a trading plan on August 30, 2024. The plan, which expires August 30, 2025, provides for the sale of (i) 900 shares of our common stock and (ii) 100% of the net vested shares resulting from the vesting of 300 restricted stock units during the plan period and subject to certain vesting conditions.
Name	Paul Chamberlain
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 30, 2024
Expiration Date	August 30, 2025
Arrangement Duration	365 days
Russell Elmer Rule Trading Arrangement, Common Stock [Member] | Russell Elmer [Member]
Trading Arrangements, by Individual
Aggregate Available	2,511	2,511
Russell Elmer Rule Trading Arrangement, Restricted Stock Units and Performance Stock Units [Member] | Russell Elmer [Member]
Trading Arrangements, by Individual
Aggregate Available	9,149	9,149
Paul Smith Rule Trading Arrangement, Common Stock [Member] | Paul Smith [Member]
Trading Arrangements, by Individual
Aggregate Available	1,153	1,153
Paul Smith Rule Trading Arrangement, Restricted Stock Units And Performance Stock Units Tranche One [Member] | Paul Smith [Member]
Trading Arrangements, by Individual
Aggregate Available	10,757	10,757
Paul Smith Rule Trading Arrangement, Restricted Stock Units [Member] | Paul Smith [Member]
Trading Arrangements, by Individual
Aggregate Available	1,019	1,019
Paul Smith Rule Trading Arrangement, Restricted Stock Units And Performance Stock Units Tranche Two [Member] | Paul Smith [Member]
Trading Arrangements, by Individual
Aggregate Available	7,902	7,902
William R. McDermott Rule Trading Arrangement, Common Stock [Member] | William R. McDermott [Member]
Trading Arrangements, by Individual
Aggregate Available	21,972	21,972
William R. McDermott Rule Trading Arrangement, Restricted Stock Units and Performance Stock Units [Member] | William R. McDermott [Member]
Trading Arrangements, by Individual
Aggregate Available	15,892	15,892
Anita Sands Rule Trading Arrangement, Common Stock [Member] | Anita Sands [Member]
Trading Arrangements, by Individual
Aggregate Available	2,229	2,229
Anita Sands Rule Trading Arrangement, Restricted Stock Units Tranche One [Member] | Anita Sands [Member]
Trading Arrangements, by Individual
Aggregate Available	428	428
Anita Sands Rule Trading Arrangement, Restricted Stock Units Tranche Two [Member] | Anita Sands [Member]
Trading Arrangements, by Individual
Aggregate Available	214	214
Paul Chamberlain Rule Trading Arrangement, Common Stock Tranche One [Member] | Paul Chamberlain [Member]
Trading Arrangements, by Individual
Aggregate Available	900	900
Paul Chamberlain Rule Trading Arrangement, Common Stock Tranche Two [Member] | Paul Chamberlain [Member]
Trading Arrangements, by Individual
Aggregate Available	300	300

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by United States (“U.S.”) generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the condensed consolidated financial statements and footnote tables. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2023 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on January 25, 2024.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.
Use of Estimates	Use of Estimates
Derivative Financial Instruments	Derivative Financial Instruments Cash flow hedging We record derivatives at fair value as either assets or liabilities on our condensed consolidated balance sheets. For derivative contracts entered into to hedge a portion of our forecasted foreign currency denominated revenues that are designated and qualify as cash flow hedges, the unrealized gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings as subscription revenues when the hedged transaction affects earnings. Derivatives not designated as hedging instruments are adjusted to fair value through earnings as other expense, net in the period during which changes in fair value occur.
Concentration of Credit Risk and Significant Customers	Concentration of Credit Risk and Significant Customers Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. We had one customer, a U.S. federal channel partner and systems integrator, that represented 27% of our accounts receivable balance as of September 30, 2024 and 11% of our total revenues for each of the three and nine months ended September 30, 2024. Based on our periodic credit evaluations, there have been no historical collection concerns with this customer. There were no customers that individually exceeded 10% of our accounts receivable balance as of December 31, 2023 or our total revenues for each of the three and nine months ended September 30, 2023. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer.
Revision of Prior Period Financial Statements	Revision of Prior Period Financial Statement s During the quarter ended June 30, 2024, the Company identified an immaterial error in the condensed consolidated statements of cash flows for the period ended March 31, 2024 relating to a misclassification between investing cash outflows and financing cash outflows. The second installment payment for a business combination completed during the quarter ended September 30, 2023, totaling $184 million, was incorrectly classified as an investing cash outflow instead of a financing cash outflow. The Company determined that the error was not material to any previously issued financial statements and will revise such error in its Quarterly Report on Form 10-Q for the three months ending March 31, 2025.
Fair Value Measurements	We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs), pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs that are supported by little or no market activity (Level 3 inputs).

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Securities, Available-for-Sale [Abstract]
Schedule of Marketable Debt Securities	The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): September 30, 2024 Amortized Gross Gross Estimated Available-for-sale debt securities: Commercial paper $ 297 $ 1 $ — $ 298 Corporate notes and bonds 4,566 41 (1) 4,606 Certificates of deposit 42 — — 42 U.S. government and agency securities 2,196 9 (1) 2,204 Mortgage-backed and asset-backed securities 103 — (14) 89 Total available-for-sale debt securities $ 7,204 $ 51 $ (16) $ 7,239 December 31, 2023 Amortized Gross Gross Estimated Available-for-sale debt securities: Commercial paper $ 349 $ — $ — $ 349 Corporate notes and bonds 3,579 10 (13) 3,576 Certificates of deposit 94 — — 94 U.S. government and agency securities 2,081 3 (6) 2,078 Mortgage-backed and asset-backed securities 102 — (16) 86 Total available-for-sale debt securities $ 6,205 $ 13 $ (35) $ 6,183
Schedule of Investments Classified by Contractual Maturity Date	The fair values of available-for-sale debt securities, by remaining contractual maturity, are as follows (in millions): September 30, 2024 Due within 1 year $ 3,410 Due in 1 year through 5 years 3,740 Instruments not due in single maturity 89 Total $ 7,239

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on Recurring Basis	The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of September 30, 2024 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,162 $ — $ 1,162 Commercial paper — 44 44 Deposits 238 — 238 U.S. government and agency securities — 4 4 Marketable securities: Commercial paper — 298 298 Corporate notes and bonds — 4,606 4,606 Certificates of deposit — 42 42 U.S. government and agency securities — 2,204 2,204 Mortgage-backed and asset-backed securities — 89 89 Total $ 1,400 $ 7,287 $ 8,687 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2023 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,215 $ — $ 1,215 Commercial paper — 79 79 Corporate notes and bonds — 2 2 Deposits 295 — 295 U.S. government and agency securities — 4 4 Marketable securities: Commercial paper — 349 349 Corporate notes and bonds — 3,576 3,576 Certificates of deposit — 94 94 U.S. government and agency securities — 2,078 2,078 Mortgage-backed and asset-backed securities — 86 86 Total $ 1,510 $ 6,268 $ 7,778

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amounts of goodwill were as follows (in millions): Carrying Amount Balance as of December 31, 2023 $ 1,231 Goodwill acquired 58 Foreign currency translation adjustments 2 Balance as of September 30, 2024 $ 1,291
Schedule of Intangible Assets	Intangible assets, net consists of the following (in millions): September 30, 2024 December 31, 2023 Developed technology $ 575 $ 516 Patents 73 72 Other 11 11 Intangible assets, gross 659 599 Less: accumulated amortization (445) (375) Intangible assets, net $ 214 $ 224
Schedule of Estimated Future Amortization Expense Related to Intangible Assets	The following table presents the estimated future amortization expense related to intangible assets held at September 30, 2024 (in millions): Years Ending December 31, Remainder of 2024 $ 22 2025 76 2026 45 2027 31 2028 26 Thereafter 14 Total future amortization expense $ 214

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net consists of the following (in millions): September 30, 2024 December 31, 2023 Computer equipment $ 2,642 $ 2,136 Computer software 107 96 Leasehold and other improvements 316 292 Furniture and fixtures 88 86 Construction in progress 43 33 Property and equipment, gross 3,196 2,643 Less: Accumulated depreciation (1,478) (1,285) Property and equipment, net $ 1,718 $ 1,358

Derivative Contracts (Tables)

Derivative Contracts (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Outstanding Derivative Contracts	The total gross fair values of derivatives designated as hedging instruments recorded within the condensed consolidated balance sheets were as follows (in millions): Condensed Consolidated Balance Sheets Location September 30, 2024 Accrued expenses and other current liabilities $ 25 Other long-term liabilities $ 10

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income, Net of Tax	The following tables show the components of accumulated other comprehensive income (loss), net of tax, in the stockholders’ equity section of our condensed consolidated balance sheets (in millions): Unrealized Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Foreign Currency Translation Adjustment Total Balance as of December 31, 2023 $ — $ (39) $ 2 $ (37) Other comprehensive (loss) income before reclassifications (27) 44 3 20 Amounts reclassified from accumulated other comprehensive loss (3) — — (3) Net current period other comprehensive (loss) income (30) 44 3 17 Balance as of September 30, 2024 $ (30) $ 5 $ 5 $ (20) Unrealized Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Foreign Currency Translation Adjustment Total Balance as of December 31, 2022 $ — $ (77) $ (25) $ (102) Other comprehensive loss before reclassifications — (4) (51) (55) Amounts reclassified from accumulated other comprehensive loss — — — — Net current period other comprehensive loss — (4) (51) (55) Balance as of September 30, 2023 $ — $ (81) $ (76) $ (157)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Common Stock Outstanding and Reserved Shares of Common Stock for Future Issuance	As of September 30, 2024, we had 206.3 million shares of common stock, net of treasury stock, outstanding and had reserved shares of common stock for future issuance as follows (in thousands): September 30, 2024 Stock plans: Options outstanding 948 RSUs (1) 6,354 Shares of common stock available for future grants: Amended and Restated 2021 Equity Incentive Plan (2) 9,579 Amended and Restated 2012 Employee Stock Purchase Plan (2) 8,119 Total shares of common stock reserved for future issuance 25,000 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed in Note 13. (2) Refer to Note 13 for a description of these plans.

Equity Awards (Tables)

Equity Awards (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of stock option activity for the nine months ended September 30, 2024 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2023 1,150 $ 603.30 Exercised (74) $ 327.00 $ 34 Forfeited (128) $ 645.02 Outstanding at September 30, 2024 948 $ 619.04 6.8 $ 261 Vested and expected to vest as of September 30, 2024 837 $ 610.33 6.8 $ 238 Vested and exercisable as of September 30, 2024 238 $ 433.25 5.9 $ 110
Schedule of Restricted Stock Unit Activity	A summary of RSU activity for the nine months ended September 30, 2024 was as follows: Number of Weighted-Average Grant-Date Fair Value (in thousands) Outstanding at December 31, 2023 6,262 $ 506.77 Granted 2,866 $ 778.65 Vested (2,309) $ 537.32 Forfeited (465) $ 562.17 Outstanding at September 30, 2024 6,354 $ 614.27 Expected to vest as of September 30, 2024 5,698

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Income Per Share	The following table presents the calculation of basic and diluted net income per share attributable to common stockholders (in millions, except for number of shares reflected in thousands and per share data): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net income $ 432 $ 242 $ 1,041 $ 1,436 Denominator: Weighted-average shares outstanding - basic 206,158 204,464 205,639 203,961 Weighted-average effect of potentially dilutive securities: Common stock options 131 122 138 118 RSUs 2,258 1,674 2,218 1,113 ESPP obligations 5 17 9 2 Weighted-average shares outstanding - diluted 208,552 206,277 208,004 205,194 Net income per share - basic $ 2.09 $ 1.18 $ 5.06 $ 7.04 Net income per share - diluted $ 2.07 $ 1.17 $ 5.00 $ 7.00 Common stock options, RSUs and ESPP obligations excluded from diluted net income per share because their effect would have been anti-dilutive 1,082 3,068 2,715 3,647

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of September 30, 2024 are presented in the table below (in millions): Remainder of 2024 $ 31 2025 135 2026 112 2027 97 2028 91 Thereafter 428 Total operating lease payments 894 Less: imputed interest (138) Present value of operating lease liabilities $ 756

Information about Geographic _2

Information about Geographic Areas and Products (Tables)	9 Months Ended
	Sep. 30, 2024
Segments, Geographical Areas [Abstract]
Revenues by Geographic Area, Based on Billing Location of Customer	Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 North America (1) $ 1,778 $ 1,452 $ 5,080 $ 4,165 EMEA (2) 700 585 2,037 1,664 Asia Pacific and other 319 251 910 705 Total revenues $ 2,797 $ 2,288 $ 8,027 $ 6,534
Schedule of Long Lived Assets by Geographic Area	Property and equipment, net by geographic area were as follows (in millions): September 30, 2024 December 31, 2023 North America (3) $ 1,080 $ 871 EMEA (2) 426 312 Asia Pacific and other 212 175 Total property and equipment, net $ 1,718 $ 1,358 (1) Revenues attributed to the United States were 94% of North America revenues for each of the three and nine months ended September 30, 2024 and 2023. (2) Europe, the Middle East and Africa (“EMEA”). (3) Property and equipment, net attributed to the United States were 78% and 79% of property and equipment, net attributable to North America as of September 30, 2024 and December 31, 2023, respectively.
Schedule of Subscription Revenue	Subscription revenues consist of the following (in millions): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Digital workflow products $ 2,398 $ 1,961 $ 6,877 $ 5,587 ITOM products 317 255 903 728 Total subscription revenues $ 2,715 $ 2,216 $ 7,780 $ 6,315

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jan. 01, 2024	Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Depreciation	$ 96		$ 98	$ 264	$ 267
Net income	$ 432		$ 242	$ 1,041	$ 1,436
Net income per share - basic (in USD per share)	$ 2.09		$ 1.18	$ 5.06	$ 7.04
Net income per share - diluted (in USD per share)	$ 2.07		$ 1.17	$ 5	$ 7
Payments to acquire businesses, net of cash acquired				$ 82	$ 279
Revision of Prior Period, Reclassification, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Payments to acquire businesses, net of cash acquired		$ 184
One Customer | Accounts Receivable | Customer Concentration Risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk				27%
One Customer | Revenue Benchmark | Customer Concentration Risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk	11%			11%
Service Life
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Depreciation	$ 24			$ 81
Net income	$ 21			$ 65
Net income per share - basic (in USD per share)	$ 0.10			$ 0.31
Net income per share - diluted (in USD per share)	$ 0.10			$ 0.31
Data Center Equipment | Service Life
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Property and equipment, useful life (in years)						5 years	4 years

Investments - Summary of Invest

Investments - Summary of Investments (Detail) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 7,204	$ 6,205
Gross Unrealized Gains	51	13
Gross Unrealized Losses	(16)	(35)
Estimated Fair Value	7,239	6,183
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	297	349
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	0
Estimated Fair Value	298	349
Corporate notes and bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	4,566	3,579
Gross Unrealized Gains	41	10
Gross Unrealized Losses	(1)	(13)
Estimated Fair Value	4,606	3,576
Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	42	94
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	42	94
U.S. government and agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,196	2,081
Gross Unrealized Gains	9	3
Gross Unrealized Losses	(1)	(6)
Estimated Fair Value	2,204	2,078
Mortgage-backed and asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	103	102
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(14)	(16)
Estimated Fair Value	$ 89	$ 86

Investments - Narrative (Detail

Investments - Narrative (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale [Abstract]
Contractual maturities	37 months
Continuous unrealized loss position, 12 months or greater, fair value	$ 16
Continuous unrealized loss position, fair value	1,419	$ 3,731
Non-marketable equity investment	$ 396	$ 268

Investments - Maturities of Ava

Investments - Maturities of Available-for-Sale Investments (Detail) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale [Abstract]
Due within 1 year	$ 3,410
Due in 1 year through 5 years	3,740
Instruments not due in single maturity	89
Total	$ 7,239	$ 6,183

Fair Value Measurements (Detail

Fair Value Measurements (Detail) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 8,687	$ 7,778
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,400	1,510
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	7,287	6,268
Cash equivalents: | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	1,162	1,215
Cash equivalents: | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	44	79
Cash equivalents: | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	238	295
Cash equivalents: | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		2
Cash equivalents: | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	4	4
Cash equivalents: | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	1,162	1,215
Cash equivalents: | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 1 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	238	295
Cash equivalents: | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		0
Cash equivalents: | Level 1 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	44	79
Cash equivalents: | Level 2 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		2
Cash equivalents: | Level 2 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	4	4
Marketable securities: | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	298	349
Marketable securities: | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	4,606	3,576
Marketable securities: | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	42	94
Marketable securities: | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	2,204	2,078
Marketable securities: | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	89	86
Marketable securities: | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	298	349
Marketable securities: | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	4,606	3,576
Marketable securities: | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	42	94
Marketable securities: | Level 2 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	2,204	2,078
Marketable securities: | Level 2 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	$ 89	$ 86

Business Combinations (Details)

Business Combinations (Details) $ in Millions		9 Months Ended
	Jul. 17, 2023 USD ($) installment	Sep. 30, 2024 USD ($)	Sep. 30, 2023	Dec. 31, 2023 USD ($)
Business Acquisition [Line Items]
Goodwill		$ 1,291		$ 1,231
Developed technology
Business Acquisition [Line Items]
Weighted average useful life (in years)		5 years	5 years
G2K Group, GmbH
Business Acquisition [Line Items]
Cash payment to acquire businesses	$ 465
Number of installments | installment	2
Net tangible liabilities	$ 1
Deferred tax liabilities	23
Goodwill	414
G2K Group, GmbH | Developed technology
Business Acquisition [Line Items]
Intangible asset acquired	$ 75
Weighted average useful life (in years)	6 years
Series of Individually Immaterial Business Acquisitions
Business Acquisition [Line Items]
Consideration transferred		$ 81

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning of period	$ 1,231
Goodwill acquired	58
Foreign currency translation adjustments	2
Goodwill, end of period	$ 1,291

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 659	$ 599
Less: accumulated amortization	(445)	(375)
Intangible assets, net	214	224
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	575	516
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	73	72
Other
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 11	$ 11

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 23	$ 21	$ 71	$ 63
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)			5 years	5 years

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Estimated Future Amortization of Intangible Assets (Details) $ in Millions	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 22
2025	76
2026	45
2027	31
2028	26
Thereafter	14
Total future amortization expense	$ 214

Property and Equipment - Proper

Property and Equipment - Property and Equipment, Net (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,196		$ 3,196		$ 2,643
Less: Accumulated depreciation	(1,478)		(1,478)		(1,285)
Property and equipment, net	1,718		1,718		1,358
Depreciation	96	$ 98	264	$ 267
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,642		2,642		2,136
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	107		107		96
Leasehold and other improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	316		316		292
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	88		88		86
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 43		$ 43		$ 33

Property and Equipment - Narrat

Property and Equipment - Narrative - (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 96	$ 98	$ 264	$ 267

Derivative Contracts - Narrativ

Derivative Contracts - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Derivative, gain (loss), statement of income or comprehensive income		Total revenues
Foreign currency derivative contracts | Designated as hedging instrument
Derivatives, Fair Value [Line Items]
Derivative, term of contract		34 months
Derivative, notional amount	$ 1,600	$ 1,600
Foreign currency derivative contracts | Not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative, notional amount	2,300	2,300	$ 1,700
Forward contracts
Derivatives, Fair Value [Line Items]
Derivative, gain (loss) on derivative, net		25
Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax	$ (2)	$ 3

Derivative Contracts - Fair Val

Derivative Contracts - Fair Value by Balance Sheet Location (Details) - Designated as hedging instrument $ in Millions	Sep. 30, 2024 USD ($)
Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, subject to master netting arrangement, before offset	$ 25
Other long-term liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, subject to master netting arrangement, before offset	$ 10

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations - Revenues Recognized from Deferred Revenues (Details) - USD ($) $ in Billions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 2.5	$ 2	$ 5.1	$ 4.1

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Transaction Price Allocated to the Remaining Performance Obligations (Details) $ in Billions	Sep. 30, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining non-cancelable performance obligations	$ 19.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	48%
Performance obligations period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	52%
Performance obligations period	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01 | Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	13 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	36 months

Debt - Narrative (Details)

Debt - Narrative (Details) $ / shares in Units, $ in Millions	1 Months Ended
	Aug. 31, 2020 USD ($)	Sep. 30, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares
Debt Instrument [Line Items]
Estimated fair value of the note based on the closing trading price (in USD per share) | $ / shares		$ 100	$ 100
2030 Notes
Debt Instrument [Line Items]
Long-term debt		$ 1,489	$ 1,488
Unamortized debt discount and unamortized debt issuance costs		11	12
Contractual interest rate, notes (percent)	1.40%
Debt term (in years)	10 years
Principal	$ 1,500	$ 1,500
Percentage of principle issued (percent)	0.9963
Payments of debt issuance costs	$ 13
Effective interest rate (percent)		1.53%
2030 Notes | Level 2
Debt Instrument [Line Items]
Convertible debt, fair value disclosures		$ 1,290	$ 1,236

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 8,666	$ 6,926	$ 7,628	$ 5,032
Other comprehensive (loss) income before reclassifications			20	(55)
Amounts reclassified from accumulated other comprehensive loss			(3)	0
Other comprehensive income (loss)	58	(66)	17	(55)
Ending balance	9,290	7,182	9,290	7,182
Unrealized Gains (Losses) on Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			0	0
Other comprehensive (loss) income before reclassifications			(27)	0
Amounts reclassified from accumulated other comprehensive loss			(3)	0
Other comprehensive income (loss)			(30)	0
Ending balance	(30)	0	(30)	0
Unrealized Gains (Losses) on Investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(39)	(77)
Other comprehensive (loss) income before reclassifications			44	(4)
Amounts reclassified from accumulated other comprehensive loss			0	0
Other comprehensive income (loss)			44	(4)
Ending balance	5	(81)	5	(81)
Foreign Currency Translation Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			2	(25)
Other comprehensive (loss) income before reclassifications			3	(51)
Amounts reclassified from accumulated other comprehensive loss			0	0
Other comprehensive income (loss)			3	(51)
Ending balance	5	(76)	5	(76)
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(78)	(91)	(37)	(102)
Other comprehensive income (loss)	58	(66)	17	(55)
Ending balance	$ (20)	$ (157)	$ (20)	$ (157)

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Detail) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	May 31, 2023
Equity [Abstract]
Shares of common stock, authorized (in shares)	600,000		600,000		600,000
Common stock, outstanding (in shares)	206,317		206,317		204,724
Common stock and treasury stock issued under employee stock plans (in shares)			2,100	2,200
Stock repurchase program, authorized amount						$ 1,500
Common stock repurchased (in shares)	300	500	500	500
Common stock repurchased	$ 225	$ 282	$ 400	$ 282
Stock repurchase program, remaining authorized amount	$ 562		$ 562

Stockholders' Equity - Outstand

Stockholders' Equity - Outstanding and Reserved Shares of Common Stock for Future Issuance (Detail) - shares shares in Thousands	Sep. 30, 2024	Dec. 31, 2023
Stock plans:
Options outstanding (in shares)	948	1,150
Total shares of common stock reserved for future issuance (in shares)	25,000
Amended and Restated 2021 Equity Incentive Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	9,579
Amended and Restated 2012 Employee Stock Purchase Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	8,119
Options outstanding
Stock plans:
Options outstanding (in shares)	948
RSUs
Stock plans:
RSUs (in shares)	6,354	6,262

Equity Awards - Narrative (Deta

Equity Awards - Narrative (Detail) $ in Millions	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($) shares	Sep. 30, 2024 USD ($) plan shares	Sep. 30, 2023 USD ($)	Dec. 31, 2021 USD ($) tranche	Dec. 31, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | plan		3
Increased in authorized shares (in shares) | shares		10,000,000
Fair value of stock options vested		$ 41
Granted (in shares) | shares		0
Total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options	$ 10	$ 10
Common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period (in years)		1 year
Restricted stock units with service condition only
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	5,900,000	5,900,000
Restricted stock units with service and performance conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	500,000	500,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period (in years)		3 years
Number of shares outstanding (in shares) | shares	6,354,000	6,354,000			6,262,000
Aggregate intrinsic value, vested		$ 1,800
Aggregate intrinsic value, outstanding	$ 5,700	5,700
Aggregated intrinsic value, expected to vest	5,100	5,100
Unrecognized compensation expense expected to be recognized	$ 3,100	$ 3,100
Performance-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)		100%
Stock-based compensation expense, net of actual and estimated forfeitures		$ 106	$ 111
Performance-based RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)		0%
Performance-based RSUs | Minimum | Vesting, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term		1 year
Performance-based RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)		200%
Performance-based RSUs | Maximum | Vesting, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term		3 years
2012 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock purchase price percentage		85%
Award offering period		6 months
2021 Performance Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Service period (in years)		2 years
2021 Performance Awards | Employee Stock | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted, value, share-based payment arrangement, before forfeiture				$ 232
Number of vesting tranches | tranche				8
Options granted, exercisable period		10 years
2021 Performance Awards | Employee Stock | Minimum | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition				2 years
2021 Performance Awards | Common stock options | Vesting, tranche one | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche two | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche three | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche five | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche six | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche seven | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Tranche eight | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%

Equity Awards - Summary of Stoc

Equity Awards - Summary of Stock Option Activity (Detail) $ / shares in Units, shares in Thousands, $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares) | shares	1,150
Exercised (in shares) | shares	(74)
Forfeited (in shares) | shares	(128)
Outstanding, ending balance (in shares) | shares	948
Vested and expected to vest (in shares) | shares	837
Vested and exercisable (in shares) | shares	238
Weighted- Average Exercise Price Per Share
Outstanding, beginning balance (in USD per share) | $ / shares	$ 603.30
Exercised (in USD per share) | $ / shares	327
Forfeited (in USD per share) | $ / shares	645.02
Outstanding, ending balance (in USD per share) | $ / shares	619.04
Vested and expected to vest (in USD per share) | $ / shares	610.33
Vested and exercisable (in USD per share) | $ / shares	$ 433.25
Weighted-average remaining contractual term, outstanding (in years)	6 years 9 months 18 days
Weighted-average remaining contractual term, vested and expected to vest (in years)	6 years 9 months 18 days
Weighted-average remaining contractual term, vested and exercisable (in years)	5 years 10 months 24 days
Aggregate intrinsic value, exercised | $	$ 34
Aggregate intrinsic value, outstanding | $	261
Aggregate intrinsic value, vested and expected to vest | $	238
Aggregate intrinsic value, vested and exercisable | $	$ 110

Equity Awards - Restricted Stoc

Equity Awards - Restricted Stock Unit Table (Details) - RSUs shares in Thousands	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares)	6,262
Granted (in shares)	2,866
Vested (in shares)	(2,309)
Forfeited (in shares)	(465)
Outstanding, ending balance (in shares)	6,354
Expected to vest (in shares)	5,698
Weighted-Average Grant-Date Fair Value Per Share
Outstanding, beginning balance (in USD per share) | $ / shares	$ 506.77
Granted (in USD per share) | $ / shares	778.65
Vested (in USD per share) | $ / shares	537.32
Forfeited (in USD per share) | $ / shares	562.17
Outstanding, ending balance (in USD per share) | $ / shares	$ 614.27

Net Income Per Share - Schedule

Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share Attributable to Common Stockholders (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net income	$ 432	$ 242	$ 1,041	$ 1,436
Denominator:
Weighted-average shares outstanding - basic (in shares)	206,158	204,464	205,639	203,961
Weighted-average shares outstanding - diluted (in shares)	208,552	206,277	208,004	205,194
Net income per share - basic (in USD per share)	$ 2.09	$ 1.18	$ 5.06	$ 7.04
Net income per share - diluted (in USD per share)	$ 2.07	$ 1.17	$ 5	$ 7
Common stock options, RSUs and ESPP obligations excluded from diluted net income per share because their effect would have been anti-dilutive (in shares)	1,082	3,068,000	2,715	3,647,000
Common stock options
Denominator:
Potentially dilutive securities (in shares)	131	122	138	118
RSUs
Denominator:
Potentially dilutive securities (in shares)	2,258	1,674	2,218	1,113
ESPP obligations
Denominator:
Potentially dilutive securities (in shares)	5	17	9	2

Provision for (Benefit from) _2

Provision for (Benefit from) Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax provision (benefit)	$ 84	$ 57	$ 234	$ (775)
Valuation allowance, deferred tax asset, increase (decrease), amount		$ 985

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Aug. 31, 2020
Debt Instrument [Line Items]
Operating lease costs	$ 33	$ 33	$ 98	$ 96
Operating lease liabilities, payments			61
Right-of-use assets obtained in exchange for operating lease liabilities			$ 21	$ 93
Weighted-average lease remaining lease term (in years)	8 years		8 years
Weighted-average discount rate (percent)	4%		4%
Non-cancelable agreement	$ 50		$ 50
Purchase agreement	805		805
Unrecognized tax benefits	$ 60		$ 60
Maximum
Debt Instrument [Line Items]
Operating lease term (in years)	10 years		10 years
2030 Notes
Debt Instrument [Line Items]
Principal	$ 1,500		$ 1,500		$ 1,500

Commitments and Contingencies_2

Commitments and Contingencies - Maturity of Operating Lease Liabilities (Details) $ in Millions	Sep. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2024	$ 31
2025	135
2026	112
2027	97
2028	91
Thereafter	428
Total operating lease payments	894
Less: imputed interest	(138)
Present value of operating lease liabilities	$ 756

Information about Geographic _3

Information about Geographic Areas and Products - Geographic Disclosures (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Revenues by geography
Total revenues	$ 2,797	$ 2,288	$ 8,027	$ 6,534
Property and equipment by geography
Property and equipment, net	$ 1,718		$ 1,718		$ 1,358
Percentage of U.S. revenues in North America	94%	94%	94%	94%
Percentage of U.S. net property and equipment in North America	78%		78%		79%
North America
Revenues by geography
Total revenues	$ 1,778	$ 1,452	$ 5,080	$ 4,165
Property and equipment by geography
Property and equipment, net	1,080		1,080		$ 871
EMEA
Revenues by geography
Total revenues	700	585	2,037	1,664
Property and equipment by geography
Property and equipment, net	426		426		312
Asia Pacific and other
Revenues by geography
Total revenues	319	$ 251	910	$ 705
Property and equipment by geography
Property and equipment, net	$ 212		$ 212		$ 175

Information about Geographic _4

Information about Geographic Areas and Products - Subscription Revenues (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Subscription revenues	$ 2,797	$ 2,288	$ 8,027	$ 6,534
Digital workflow products
Segment Reporting Information [Line Items]
Subscription revenues	2,398	1,961	6,877	5,587
ITOM products
Segment Reporting Information [Line Items]
Subscription revenues	317	255	903	728
Total subscription revenues
Segment Reporting Information [Line Items]
Subscription revenues	$ 2,715	$ 2,216	$ 7,780	$ 6,315